Technology License Agreement Sample Contracts
AMENDMENT TO TECHNOLOGY LICENSE AGREEMENT BETWEEN NICHE TECHNOLOGIES, INC. (DBA NICHE PROPERTIES) AND FAIRWAY PROPERTIES, INC. DATED MARCH 5, 2010Technology License Agreement • April 26th, 2010 • Fairway Properties, Inc. • Services-computer programming, data processing, etc.
EX-10.3 4 dex103.htm TECHNOLOGY LICENSE AGREEMENT TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • May 5th, 2020 • Florida
THIS TECHNOLOGY LICENSE AGREEMENT (the “Agreement”) is made and entered into this 8TH day of December, 2009, by and between SenCer Inc., a New York corporation (“Licensor”), and GreenCell, Incorporated, a to be formed Florida Corporation (the “Company”).
EXHIBIT 10.9 AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT This Amended and Restated Technology License Agreement (the "Agreement") is made and entered into as of the 19th day of May, 2005, by and between TERRA INSIGHT CORPORATION, a Delaware...Technology License Agreement • May 25th, 2005 • Compuprint Inc • Miscellaneous manufacturing industries • New York
RECITALSTechnology License Agreement • June 8th, 2006 • Photronics Inc • Semiconductors & related devices • Delaware
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • March 15th, 2012 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • California
THIS AGREEMENT (“Agreement”) is made effective as of December 30, 2005 (the “Effective Date”) and entered into by and between Surgi-Vision, Inc., a Delaware corporation (“Licensor”) and Advanced Bionics Corporation (“Licensee”) (individually, a “Party” and collectively, the “Parties”).
CEVEC, Yuhan sign deal for immortalized cell linesTechnology License Agreement • May 12th, 2021
ContractTechnology License Agreement • March 7th, 2022 • Polestar Automotive Holding UK LTD • Motor vehicles & passenger car bodies • Macau
Certain identified information marked with “[***]” has been omitted from this document because it is both (i) not material and (ii) the type that the registrant treats as private or confidential
Technology License Agreement*Technology License Agreement • March 10th, 2008 • Sonics, Inc. • Semiconductors & related devices • Texas
This Technology License Agreement, (hereinafter “Agreement”) is made effective the 31st day of January, 2003 (the “Effective Date”) by and between Texas Instruments Incorporated, a Delaware corporation, having its principal place of business at 12500 TI Boulevard, Dallas, Texas 75243, and its Subsidiaries (hereinafter “TI”), and Sonics, Inc., a Delaware corporation, having its principal place of business at 2440 West. El Camino Real, Suite 600, Mountain View, CA 94040 (hereinafter “Sonics”). TI and Sonics may be referred to individually as a “Party” or collectively as the “Parties.”
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • December 28th, 2011 • Mri Interventions, Inc. • Surgical & medical instruments & apparatus • Minnesota
THIS TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made effective as of March 19, 2008 (the “Effective Date”) and entered into by and between Surgi-Vision, Inc., a Delaware corporation (“SVI”), and Cardiac Pacemakers, Inc. (“CPI”) (individually, a “Party” and collectively, the “Parties”).
TECHNOLOGY LICENSE AGREEMENT CONFIDENTIAL TREATMENT REQUESTEDTechnology License Agreement • March 2nd, 2009 • Helix BioPharma Corp • Pharmaceutical preparations • Ontario
INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND IS IDENTIFIED BY THREE ASTERISKS, AS FOLLOWS “* * *”, AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
RECITALSTechnology License Agreement • March 30th, 1998 • Spiros Development Corp Ii Inc • Pharmaceutical preparations • California
TECHNOLOGY LICENSE AGREEMENT *Confidential treatment has been requested and a complete copy of this agreement has been filed with the Commission. Redacted portions are marked throughout.Technology License Agreement • August 31st, 2009 • Neptune Technologies & Bioressources Inc. • Quebec
This TECHNOLOGY LICENSE AGREEMENT (the “Agreement”) entered into this 15th day of October, 2008 (the “Effective Date”) by and between Neptune Technologies & Bioressources Inc. (“Licensor”) and Neuro Vimer Pharm Inc. renamed NeuroBioPharm Inc. (the “Company”) (Licensor and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”). Agreement reviewed the 20 February 2009.
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • April 10th, 2013 • BioAmber Inc. • Industrial organic chemicals • Delaware
This Agreement (the “Agreement”), made and effective as of the Effective Date, by and between Celexion, LLC, a Delaware limited liability company having its principal place of business at One Memorial Drive, Suite 7, Cambridge, MA 02142 (hereinafter referred to as “Celexion” or “Licensor”) and DNP Green Technology, Inc., a Delaware corporation having its principal place of business at 1250 Rene-Levesque West, Suite 4110, Montreal, QC, Canada, H3B 4W8 (hereinafter referred to as “DNP Green” or “Licensee”).
Technology License AgreementTechnology License Agreement • May 2nd, 2023
EXHIBIT 10.19 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. Oak Technology, Confidential TECHNOLOGY LICENSE AGREEMENT THIS...Technology License Agreement • June 28th, 2002 • Tvia Inc • Semiconductors & related devices • California
SONICS, INC. RESTATED AND AMENDED TECHNOLOGY LICENSE AGREEMENT FOR TOSHIBA*Technology License Agreement • March 10th, 2008 • Sonics, Inc. • Semiconductors & related devices • California
RECITALSTechnology License Agreement • August 30th, 2000 • Curon Medical Inc • Electromedical & electrotherapeutic apparatus • California
EX-10 2 filename2.htmTechnology License Agreement • May 5th, 2020 • Arizona
[*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • April 10th, 2013 • BioAmber Inc. • Industrial organic chemicals • Delaware
This Technology License Agreement (hereinafter “Agreement”) dated February 15th, 2012 (the “Effective Date”) is by and among Sinoven Biopolymers, Inc., a corporation duly organized and existing under the laws of the State of Delaware, having its principal place of business in Malvern, Pennsylvania (hereinafter called “Sinoven”); NatureWorks LLC, a limited liability company organized and existing under the laws of the State of Delaware, having its principal place of business in Minnetonka, Minnesota (hereinafter called “NatureWorks”); AmberWorks LLC, a limited liability company duly organized and existing under the laws of the State of Delaware, having its principal place of business in Plymouth, Minnesota (hereinafter called “LLC”), and BioAmber, Inc. a corporation duly organized and existing under the laws of the State of Delaware (hereinafter called “BioAmber”).
THIS TECHNOLOGY LICENCE AGREEMENT (the "Agreement") is made the 8th day of June 2008.Technology License Agreement • June 8th, 2010 • Exmovere Holdings, Inc. • Blank checks • Nevada
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained herein, the receipt and sufficiency arc acknowledged, the parties hereby agree as follows:
EX-10.49 3 exh1049.htm TECHNOLOGY LICENSE AGREEMENT. Vertigro Algae Technologies LLC VERTIGRO ALGAE TECHNOLOGIES LLC TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • May 5th, 2020 • Texas
TECHNOLOGY LICENSE AMENDMENT Effective June 30, 2000, this TECHNOLOGY LICENSE AMENDMENT ("Amendment") among NCT Group, Inc. ("NCT"), a Delaware corporation, Advancel Logic Corporation. ("Advancel"), a California corporation and a wholly owned...Technology License Agreement • August 21st, 2000 • NCT Group Inc • Miscellaneous electrical machinery, equipment & supplies • Delaware
PALMCHIP TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • June 26th, 2006 • Wintegra Inc • Semiconductors & related devices • California
Technology License AgreementTechnology License Agreement • July 7th, 2011 • China Ming Yang Wind Power Group LTD • Engines & turbines
In this Contract, Party B transfers the use right of technological know-how of 1.5MW wind turbine design and manufacturing technology and engineering service technology to Party A and Party A shall pay relevant charges. The following agreement is hereby concluded between and abided by the two parties through consultation on the basis of equality and truly and sufficiently expressing their will according to “Contract Law of the People’s Republic of China”.
ADDENDUM TO TECHNOLOGY LICENSE AGREEMENT by and between AF CHEMICALS LLC and LANTERN PHARMA, INC.Technology License Agreement • April 16th, 2020 • Lantern Pharma Inc. • Pharmaceutical preparations
This Addendum is attached to and forms part of the Technology License Agreement by and between Lantern Pharmaceuticals Inc., a Texas corporation (hereinafter referred to as “LANTERN”) having principal offices at 4287 Beltline Rd., Suite #270, Addison, TX 75001 and AF Chemicals, LLC, a Californian Limited Liability Company having principal offices at 5545 Coral Reef, La Jolla, CA 92037 (hereinafter referred to as “AFC”) as of February 8, 2016 (the “EFFECTIVE DATE”) (hereinafter the “LANTERN AFC ADDENDUM”). LANTERN and AFC are sometimes each individually referred to hereinafter as a “Party” and collectively referred to hereinafter as the “Parties”. To the extent that any of the terms or conditions contained in this LANTERN AFC ADDENDUM may contradict or conflict with any of the terms or conditions of the Technology License Agreement dated January 15, 2015, it is expressly understood and agreed that the terms of this LANTERN AFC ADDENDUM shall take precedence and supersede the Technology
TECHNOLOGY LICENSE AGREEMENT BY AND AMONG KAMADA LTD. AND BAXTER HEALTHCARE S.A. DATED: AUGUST 23, 2010 TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
THIS TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and entered into as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”), by and among Kamada, Ltd., an Israeli corporation, having a principal place of business at Science Park, Kiryat Weizmann, 7 Sapir Street, P.O. Box 4081, Ness Ziona 74140, Israel (“Kamada”) and Baxter Healthcare SA (“Baxter”) a Swiss corporation having a principal place of business at Postfach, 8010, Zurich, Switzerland.
Nmap OEM Technology License AgreementTechnology License Agreement • February 8th, 2022 • Washington
THIS NMAP TECHNOLOGY LICENSE AGREEMENT (together with all exhibits and other attachments hereto, the “Agreement”) is entered into and effective as of the last signature date set forth below, or 14 days after the first signature on the fully executed contract, whichever is earlier (“Effective Date”), by and between (“Licensee”), and Insecure.Com LLC, a Delaware company located at 9450 SW Gemini Dr #1337, Beaverton, OR 97008-7105 (“Insecure”).
Exhibit 10.1 ------------Technology License Agreement • September 19th, 2008 • Copytele Inc • Computer peripheral equipment, nec
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • September 21st, 2009 • Maxygen Inc • Services-commercial physical & biological research • New York
This Technology License Agreement (this “Agreement”) is entered into as of the 18th day of September, 2009 (“Effective Date”) by and between Maxygen, Inc., a Delaware corporation with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“Maxygen”), and Perseid Therapeutics LLC, a Delaware limited liability company with its principal place of business at 515 Galveston Drive, Redwood City, California 94063 (“CPC”). Maxygen and CPC are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • September 29th, 2014 • Exelis Inc. • Communications equipment, nec • Virginia
This TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) dated September 25, 2014 by and among EXELIS INC., an Indiana corporation (“Exelis”), and VECTRUS, INC., an Indiana corporation (“Vectrus”, Exelis and Vectrus, each a “Party”) shall become effective as of the Distribution Date.
AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • June 18th, 2024 • Pluri Inc. • Biological products, (no disgnostic substances)
THIS AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT is made and entered into as of June 12, 2024, as an amendment and restatement by the Parties to such Technology License Agreement dated as of 23 February, 2022, as amended on such date (jointly, the “License Agreement”), between (i) Pluri Biotech Ltd. (formerly known as Pluristem Ltd.), a private limited company incorporated and registered under the laws of the State of Israel, Reg. No. 513371666, having its registered address at M.T.M – Scientific Industries Centre, building 5, Haifa 3508409, Israel (hereinafter referred to as the “Licensor”), and (ii) Ever After Foods Ltd. (formerly known as Plurinuva Ltd.), a company incorporated in Israel, Reg. No. 516502556 with a registered address at M.T.M – Scientific Industries Centre, building 5, Haifa 3508409, Israel (hereinafter referred to as the “Licensee”). The Licensor and the Licensee shall hereinafter referred to as the “Parties” and each as a “Party”.
TECHNOLOGY LICENSE AGREEMENT BETWEENTechnology License Agreement • July 25th, 2017 • Q BioMed Inc. • Pharmaceutical preparations • Oklahoma
This Technology License Agreement (“Agreement”) is by and between the Rajiv Gandhi Center for Biotechnology, an autonomous research institute under the Govt. of India, located at Thycaud (PO), Poojappura, Thiruvananthapuram, Kerala State 695014, India (“RGCB”), the Oklahoma Medical Research Foundation, a nonprofit corporation, located at 825 NE 13th Street, Oklahoma City, OK 73104 ("OMRF") and QBiomed, Inc, a for-profit corporation, with offices at 501 Madison Ave, 14th Floor, New York, NY 10022 and its wholly-owned subsidiary, Q BioMed Cayman SEZC, a Cayman corporation (collectively, "COMPANY"). OMRF, RGCB and COMPANY shall be individually referred to as a “Party” and collectively referred to as “Parties” in this Agreement.
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • April 5th, 2023 • GBT Technologies Inc. • Services-management consulting services • Nevada
THIS TECHNOLOGY LICENSE AGREEMENT (the “Agreement”) is made and entered into this 3 day of April, 2023, (the “Effective Date”), by and between Trend Innovations Holding, Inc., a Nevada corporation (“Licensor”), and, GBT Technologies, Inc., a Nevada corporation (“GBT”), GBT Tokenize Corp, a Nevada limited liability company and a 50% owned subsidiary of GBT (“Subsidiary” and together with GBT, the “Company”).
EX-10.9 52 dex109.htm AGMT. S.C. JOHNSON & SON- JOHNSONDIVERSEYTechnology License Agreement • May 5th, 2020
Exhibit 10.9 EXECUTION COPY [EXPLANATORY NOTE: CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE SYMBOL “[**]” HAS BEEN INSERTED IN PLACE OF THE PORTIONS SO OMITTED.] AGREEMENT BETWEEN S. C. JOHNSON & SON, INC. AND S. C. JOHNSON COMMERCIAL MARKETS, INC.
TECHNOLOGY LICENSE AGREEMENT This Agreement is made and entered into as of the Effective Date, by and between:Technology License Agreement • May 5th, 2020 • Michigan
Dow Global Technologies LLC, a limited liability company existing under the laws of the State of Delaware, United States of America having its principal place of business at 2040 Dow Center, Midland, Michigan 48674 (hereinafter called “Licensor”), and